WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 2 fonti

Ozempic maker Novo Nordisk cuts sales and profit forecasts again

Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug market

Raccontata da

theguardian.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

theguardian.comStai leggendo7 mesi fa

Ozempic maker Novo Nordisk cuts sales and profit forecasts again

Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug market

fortune.com7 mesi fa

Novo Nordisk wants to keep its crown leading the weight-loss drugs pack. Despite outlook downgrades and…

“The ultimate defense in our industry is in innovation,” Karsten Munk Knudsen told Fortune in an exclusive interview.

Leggi questa versione → originale

Timeline cronologica

mercoledì 5 novembre 2025·theguardian.com
Ozempic maker Novo Nordisk cuts sales and profit forecasts again
Downgrade comes as Danish company continues to lose ground to Mounjaro firm Eli Lilly in weight-loss drug market
giovedì 6 novembre 2025·fortune.com
Novo Nordisk wants to keep its crown leading the weight-loss drugs pack. Despite outlook downgrades and lawsuits, its CFO has a plan |…
“The ultimate defense in our industry is in innovation,” Karsten Munk Knudsen told Fortune in an exclusive interview.